Methods Development and Validation
The technical expertise of our cGMP/GLP compliant drug development facilities are equipped to develop and validate all of the test methods required for aerosol products to meet FDA, EMEA and Health Canada requirements.
- Protocol development
- NDA required in vitro BA testing
- ANDA required in vitro BE testing
- Report generation in FDA submittable format
- Statistical analysis in FDA submittable format